Home » Tech
RODENSTOCK: MyConTM 2
- By Editorial Team
- September 19, 2024
Over one year ago, Rodenstock developed a solution to control the progression of myopia in children. The result was the release of MyConTM lenses – designed to not only correct myopia but also control the length growth of the eye in order to slow down the progression of myopia. In 2024, with MyCon 2, Rodenstock now offers a lens with improved imaging properties by customising the lens to the fit of the frame and thus to the child’s unique face. This approach includes the four individual wearing parameters, the pupil distance (PD), the pantoscopic tilt (PT), the corneal vertex distance (CVD) and the face form angle (FFA), which help to adapt the lens even more precisely. By using these parameters, improved imaging properties can be achieved in the focus area of the lens while maintaining the effect of myopia control in the periphery.
The principle of myopia control with horizontal asymmetric peripheral defocus areas, on which MyConTM lenses are based, was tested in an independent clinical study over a period of 5 years.
Study results show a 40% reduction in myopia progression and a 56% reduction in eye length growth after two years and 35% after four to five years in European children compared to conventional single vision lenses.